American Cancer Society. (2025). Breast cancer HER2 status. Cancer.org. https://www.cancer.org/cancer/types/
breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-her2-status.html
American Cancer Society. (2021). Breast cancer hormone receptor status. Cancer.org. https://www.cancer.org/cancer/types/
breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-hormone-receptor-status.html
American Cancer Society. (2023). Your breast pathology report: Breast cancer. Cancer.org. https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/understanding-your-pathology-report/breast-pathology/breast-cancer-pathology.html
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., Yamashita, T., Lu, Y. S., Inoue, K., Takahashi, M., Pápai, Z., Longin, A. S., Mills, D., Wilke, C., Hirawat, S., Juric, D., … SOLAR-1 Study Group (2019). Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. The New England journal of Medicine, 380(20), 1929–1940. https://doi.org/10.1056/NEJMoa1813904
Brett, J. O., Spring, L. M., Bardia, A., & Wander, S. A. (2021). ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Research: BCR, 23(1), 85. https://doi.org/10.1186/s13058-021-01462-3
Canadian Breast Cancer Network. (2025). Workshop: Understanding your pathology report. https://cbcn.ca/en/workshop-understanding-your-pathology-report
Erber, R., & Hartmann, A. (2020). Understanding PD-L1 testing in breast cancer: A practical approach. Breast Care (Basel, Switzerland), 15(5), 481–490. https://doi.org/10.1159/000510812
Healthline. (2024). PIK3CA mutations in breast cancer: What does it mean? https://www.healthline.com/health/
metastatic-breast-cancer/pik3ca-mutation-and-breast-cancer
Living Beyond Breast Cancer. (2024). Next-generation sequencing (NGS) test. https://www.lbbc.org/about-breast-cancer/testing/biomarker/next-generation-genome-sequencing
MyPathologyReport.ca. (2023). Pathology for patients. https://www.mypathologyreport.ca/
Nolan-Pleckham, M. (2023). The Ki-67 proliferation marker test and breast cancer treatment. Verywell Health. https://www.verywellhealth.com/ki-67-tumor-marker-test-430609
Susan G. Komen. (2023). Contents of a pathology report. https://www.komen.org/breast-cancer/diagnosis/pathology-reports/contents/